Adriana Bos-Mikich

Prof. Adriana Bos-Mikich


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2018 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
ABAdriana Bos-Mikich
Adriana Bos-Mikich
RORicardo de Oliveira
Ricardo de Oliveira
NFNilo Frantz
Nilo Frantz

4 January 2019 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
ABAdriana Bos-Mikich
Adriana Bos-Mikich
MFMarcelo O. Ferreira
Marcelo O. Ferreira
RORicardo de Oliveira
Ricardo de Oliveira
NFNilo Frantz
Nilo Frantz

9 November 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
ABAdriana Bos-Mikich
Adriana Bos-Mikich
FBFabiana F Bressan
Fabiana F Bressan
RRRafael R. Ruggeri
Rafael R. Ruggeri
YWYeda Watanabe
Yeda Watanabe
FMFlávio Vieira Meirelles
Flávio Vieira Meirelles
Parthenogenetic activation of human oocytes obtained from infertility treatments has gained new interest in recent years as an alternative approach to create embryos with no reproductive purpose for research in areas such as assisted reproduction technologies itself, somatic cell, and nuclear transfer experiments and for derivation of clinical grade pluripotent embryonic stem cells for regenerative medicine. Different activating methods have been tested on human and nonhuman oocytes, with varying degrees of success in terms of parthenote generation rates, embryo development stem cell derivation rates. Success in achieving a standardized artificial activation methodology for human oocytes and the subsequent potential therapeutic gain obtained from these embryos depends mainly on the availability of gametes donated from infertility treatments. This review will focus on the creation of parthenotes from clinically unusable oocytes for derivation and establishment of human parthenogenetic stem cell lines and their potential applications in regenerative medicine.

1 January 2020 in JBRA Assisted Reproduction
Verified
Journal Article
Open access
NFNilo Frantz
Nilo Frantz
MFMarcelo Ferreira
Marcelo Ferreira
MKMarcos Iuri Kulmann
Marcos Iuri Kulmann
GFGerta Frantz
Gerta Frantz
ABAdriana Bos-Mikich
Adriana Bos-Mikich
RORicardo Oliveira
Ricardo Oliveira
The aim of the present case series was to describe our experience with the use of PRP on patients with refractory thin endometria. This retrospective analysis included 24 IVF cycles in which patients presenting different infertility factors received intrauterine PRP infusion prior to embryo transfer. Outcomes of interest were: clinical and ongoing pregnancies, miscarriages, and births. 54% of the cycles in which PRP was employed resulted in ongoing gestation or birth; 12.5% of the cycles ended in miscarriages. Our data suggest that PRP improves intrauterine receptivity to embryo implantation, regardless of whether the endometrium reached the appropriate growth for embryo transfer.

20 January 2010 in Reproduction in Domestic Animals
Verified
Journal Article
Closed access
PDF file
MFM Ferreira
M Ferreira
ABAdriana Bos-Mikich
Adriana Bos-Mikich
NFN Frantz
N Frantz
JRJl Rodrigues
Jl Rodrigues
ABAL Brunetto
AL Brunetto
GSG Schwartsmann
G Schwartsmann

9 October 2012 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
ABAdriana Bos-Mikich
Adriana Bos-Mikich
LMLis Marques
Lis Marques
JRJosé Luiz Rodrigues
José Luiz Rodrigues
NLNívia Lothhammer
Nívia Lothhammer
NFNilo Frantz
Nilo Frantz